| C35H67N17O11 | 902.03 | 81187-14-6 | H-Arg-Lys-Arg-Ser-Arg-Ala-Glu-OH | |
| C46H91N21O10 | 1098.36 | 152246-44-1 | H-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH | |
| Autocamtide-2 | C65H118N22O20 | 1527.79 | 129198-88-5 | H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu-OH |
| Autocamtide-2-Related Inhibitory Peptide, AIP, (Ala9)-Autocamtide-2 | C64H116N22O19 | 1497.76 | 167114-91-2 | H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH |
| (Ala286)-Calmodulin-Dependent Protein Kinase II (281-302), (Ala286)-CaMK-II (281-302) | C111H191N39O29S2 | 2600.12 | 141055-85-8 | H-Met-His-Arg-Gln-Glu-Ala-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-OH |
| Calmodulin-Dependent Protein Kinase II (281-309), CaMK-II (281-309) | C146H254N46O39S3 | 3374.11 | H-Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala-OH | |
| Calmodulin-Dependent Protein Kinase II (290-309) | C103H185N31O24S | 2273.86 | 115044-69-4 | H-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala-OH |
| cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide (human, mouse, rabbit, rat), PKI-α (5-22) amide (human, mouse, rabbit, rat), Wiptide | C84H137N29O26 | 1969.19 | 100853-58-5 | H-Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 |
| cAMP-Dependent Protein Kinase Inhibitor-α (5-24) (human, mouse, rabbit, rat), PKI-α (5-24) (human, mouse, rabbit, rat), IP 20 | C94H148N32O31 | 2222.41 | 99534-03-9 | H-Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp-OH |
| C32H49N6O10PS | 740.82 | 158778-21-3 | Cyclo(-Gly-Tyr(PO3H2)-Val-Pro-Met-Leu) | |
| Ephrin-A2-Selective YSA-Peptide, LERK-6-Selective YSA-Peptide, HEK7-L-Selective YSA-Peptide | C59H86N12O20S2 | 1347.53 | 532441-10-4 | H-Tyr-Ser-Ala-Tyr-Pro-Asp-Ser-Val-Pro-Met-Met-Ser-OH |
| C59H113N29O16 | 1484.73 | 102579-44-2 | H-Gln-Arg-Arg-Gln-Arg-Lys-Ser-Arg-Arg-Thr-Ile-OH | |
| C34H64N14O11 | 844.97 | 57836-10-9 | H-Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg-OH | |
| H1-7 | C31H58N14O9 | 770.89 | 65189-70-0 | H-Arg-Arg-Lys-Ala-Ser-Gly-Pro-OH |
| C101H172N30O32 | 2318.66 | 137348-21-1 | H-Lys-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Ala-Leu-Leu-Arg-OH | |
| C28H56N12O7 | 672.83 | 121145-48-0 | H-Lys-Arg-Thr-Leu-Arg-OH | |
| Malantide | C72H124N22O21 | 1633.91 | 86555-35-3 | H-Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile-OH |
| MAPKK2 (1-16) (human, mouse, rat), Dual Specifity Mitogen-Activated Protein Kinase Kinase 2 (1-16) (human, mouse, rat), MAP Kinase Kinase 2 (1-16) (human, mouse, rat), MEK2 (1-16) (human, mouse, rat), ERK Activator Kinase 2 (1-16) (human, mouse, rat), MAPK/ERK Kinase 2 (1-16) (human, mouse, rat) | C81H144N24O19S | 1790.25 | 496957-39-2 | H-Met-Leu-Ala-Arg-Arg-Lys-Pro-Val-Leu-Pro-Ala-Leu-Thr-Ile-Asn-Pro-OH |
| C60H117N21O11 | 1308.72 | 152246-40-7 | Myristoyl-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH | |
| C42H82N12O8 | 883.19 | 125678-68-4 | Myristoyl-Lys-Arg-Thr-Leu-Arg-OH |
